Medicine and Dentistry
Coronary Computed Tomography Angiography
90%
Fluorine-18
78%
Coronary Artery Disease
75%
Troponin I
72%
Cardiac Troponin
64%
Computed Tomography of the Heart
58%
Positron Emission Tomography
58%
Myocardial Infarction
55%
Abdominal Aortic Aneurysm
55%
Angina pectoris
55%
Acute Coronary Syndrome
55%
Coronary Angiography
50%
Stable Angina Pectoris
50%
Troponin
46%
Computer Assisted Tomography
44%
Magnetic Resonance Imaging
42%
Coronary Artery
41%
Aortic Valve Replacement
41%
Aortic Stenosis
40%
Cardiac Magnetic Resonance Imaging
39%
Antiplatelet
39%
Thorax Pain
39%
Heart Muscle Injury
38%
Microcalcification
38%
Ischemic Heart Disease
36%
Myocardium
36%
Placebo
36%
Meta-Analysis
34%
Systematic Review
34%
Diseases
34%
Iron Oxide
33%
Radioactive Tracer
33%
Angina Pectoris
32%
Cardiology
31%
Cell Proliferation
31%
Hemodynamic
30%
Prevalence
29%
Aneurysm
29%
Risk Stratification
27%
Hepatitis C
27%
Long Untranslated RNA
27%
Apelin
27%
Aortic Wall
27%
Sirtuin1
27%
Lipoprotein
27%
Maturity Onset Diabetes of the Young
27%
Ticagrelor
27%
Arterial Stiffness
27%
Smooth Muscle
27%
Pulse Wave Velocity
27%
Pulmonary Hypertension
27%
Positron Emission Tomography-Computed Tomography
27%
Quality of Life
27%
Biological Activity
27%
Cigarette Smoking
27%
Hepatitis C Virus
27%
Treatment Duration
27%
Patient History of Heart Transplantation
27%
Phospholipid
27%
Clinical Trial
26%
Isotopes of Calcium
25%
Randomized Controlled Trial
25%
Cardiovascular Disease
22%
Lung Nodule
22%
Odds Ratio
22%
Echocardiography
21%
Heart Valve Prosthesis
20%
Fluorodeoxyglucose F 18
20%
Coronary Risk
18%
Cardiovascular System
18%
Heart Death
16%
Ischemic Cardiomyopathy
16%
In Vitro
13%
Cancer
13%
Diaphoresis
13%
Microcytic Anemia
13%
Gadolinium
13%
Hazard Ratio
13%
Disability Adjusted Life Years
11%
Vascular Smooth Muscle Cell
11%
Biological Marker
11%
Imaging Technique
11%
Population Research
10%
All Cause Mortality
9%
Identified Patient
9%
Aneurysm Rupture
9%
Heart Muscle Perfusion
9%
Heart Function
9%
Lifespan
9%
Disease Process
9%
Cost-Effectiveness Analysis
9%
Health Care Cost
9%
Chronic Disease
9%
Cardiac Computed Tomography
9%
Molecular Imaging
8%
High Risk Population
7%
Infusion
7%
Heart Muscle Revascularization
7%
Disease Exacerbation
7%
Blood Pressure
6%
Bleeding
6%
Diabetes
6%
Contrast Medium
6%
Congestive Heart Failure
6%
Myocardial Disease
6%
Infective Endocarditis
6%
Sphygmomanometry
6%
Major Bleeding
6%
Extracellular Space
6%
Pannus
6%
Cardiothoracics
6%
Cardiovascular Imaging
6%
Clinical Management
6%
Personalized Medicine
6%
Post-Hoc Analysis
6%
Intervention Study
6%
Diastolic Blood Pressure
6%
Intravascular Space
6%
Systolic Blood Pressure
6%
Calcium Derivative
6%
Clinical Formulation
6%
MRI Contrast Agent
6%
Mangafodipir
6%
Muscle Contractility
6%
Thrombus
6%
Smoking Habit
6%
Macrophage
5%
Cardiac Fibrosis
5%
Volunteer
5%
Cellular Imaging
5%
Comorbidity
5%
Hypoxia
5%
ST Segment Elevation Myocardial Infarction
5%
Clinical Imaging
5%
Ventricular Hypertrophy
5%
Adverse Event
5%
Angiogenesis
5%
Aortic Valve
5%
Human Specimen
5%
Extracellular Matrix
5%
Logistic Regression Analysis
5%
Brain Natriuretic Peptide
5%
Cohort Study
5%
Interstitial Cell
5%
Pharmacology, Toxicology and Pharmaceutical Science
Troponin I
100%
Acute Coronary Syndrome
82%
Troponin
68%
Aortic Stenosis
67%
Abdominal Aortic Aneurysm
55%
Fluorine 18
50%
Heart Infarction
49%
Heart Muscle Injury
42%
Inflammation
42%
Antiplatelet
39%
Coronary Artery Disease
35%
Coronary Risk
34%
Tracer
33%
Iron Oxide
33%
Heart Muscle Fibrosis
33%
Clinical Trial
30%
Cardiovascular Disease
30%
Aneurysm
29%
Biological Activity
27%
Hepatitis C Virus
27%
Lipoprotein A
27%
Pulmonary Hypertension
27%
Nanoparticle
27%
Vascular Disease
27%
Coronary Artery Atherosclerosis
27%
Congestive Heart Failure
27%
Angina Pectoris
27%
Ticagrelor
27%
Hepatitis C
27%
Phospholipid
27%
Apelin
27%
Fluorodeoxyglucose F 18
20%
Heart Death
20%
Fibrosis
19%
All Cause Mortality
17%
Gadolinium
15%
Placebo
15%
Biological Marker
14%
Bleeding
13%
Calcium Derivative
13%
Mangafodipir
13%
Stable Angina Pectoris
13%
Normal Human
13%
Cohort Study
12%
Gold Nanoparticle
11%
Aneurysm Rupture
9%
Nanomaterial
7%
Disease Exacerbation
7%
Ischemic Heart Disease
6%
Cerebrovascular Accident
6%
Heart Ventricle Hypertrophy
5%
Brain Natriuretic Peptide
5%
ST Segment Elevation Myocardial Infarction
5%
Neovascularization (Pathology)
5%
Adverse Event
5%
Comorbidity
5%
Hypoxia
5%